CLX Financial Facts
Diluted net earnings per share: 1.36Research and development costs: 31M
See Full Income Statement
Goodwill: 1.2B
Commitments and contingencies: 0
See Full Balance Sheet
Clorox Corporation (CLX) Earnings
|
Expand Research on CLX
| Next EPS Date | 4/30/24 | EPS Growth Rate | -9.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +117.1% | Revenue Growth Rate | -2.1% |
| Average % Move 1-Wk after EPS | +6.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/3/20 |  |
Q420 | $2.41 | $1.99 | +$0.42 | $1.98B | $1.87B |  |
 | | Details |
| 11/2/20 | |
Q121 | $3.22 | $2.32 | +$0.90 | $1.92B | $1.76B | |
| | Details |
| 2/4/21 | |
Q221 | $2.03 | $1.78 | +$0.25 | $1.84B | $1.75B | |
| | Details |
| 5/1/20 | |
Q320 | $1.89 | $1.67 | +$0.22 | $1.78B | $1.71B |  |
| | Details |
| 4/30/21 | |
Q321 | $1.62 | $1.48 | +$0.14 | $1.78B | $1.87B | |
| | Details |
| 8/3/21 | |
Q421 | $0.95 | $1.36 | -$0.41 | $1.8B | $1.92B | = | | | Details |
| 5/2/23 | Q323 | $1.51 | $1.22 | +$0.29 | $1.92B | $1.82B | = | | | Details | |
| 2/3/22 | |
Q222 | $0.66 | $0.84 | -$0.18 | $1.69B | $1.66B | = | | | Details |
